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Abstract. Chronic neurological disorders in their advanced phase are
characterized by a progressive loss of mobility (use of upper and lower
limbs), speech and social life. Some of these pathologies, such as amy-
otrophic lateral sclerosis and multiple sclerosis, are paradigmatic of these
deficits. High technology communication instruments, such as eye track-
ing, can be an extremely important possibility to reintroduce these pa-
tients in their family and social life, in particular when they suffer severe
disability.
This paper reports and describes the results of an ongoing experimen-
tation about Eye Tracking impact on the quality of life of amyotrophic
lateral sclerosis patients. The aim of the experimentation is to evaluate
if and when eye tracking technologies have a positive impact on patients’
lives.
1 Introduction
Persons with neurodegenerative diseases are affected by several kinds of symp-
toms and problems during the development of the illness (sometimes over a
long span of years), that have a severe impact over the quality of life. In ad-
vanced phases, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS)
are characterized by the complete loss of communication abilities, even with
common augmentative/substitutive systems, due to the total loss of movements
of limbs and neck and immobilization, with a total dependence on other persons
for the common activities of daily life.
A great deal of literature highlights the various aspects related to the care
and to improving the quality of life of these patients, through palliative care.
In palliative care, it is fundamental to control pain, symptoms, and social, psy-
chological and spiritual problems. They aim at improving the quality of life
of patients and their families. This type of care must adapt, day after day, to
the needs of the patients and of their family. Every treatment needs to be re-
examined continuously. From the literature we find that home is the ideal place
where to apply palliative care. The efforts to improve (or to allow) an effective
communication in ALS belong fully to the topic of palliative care. Patients with
very severe disability, thanks to communication tools, may have chances to re-
enter their social and family life [1]. Such systems may allow ALS or MS patients
to gain autonomy, even if limited, in their personal life choices.
The potential of eye tracking in ALS is extremely high, since these patients
retain their full cognitive capabilities, and while paralysis progresses, in most
cases eye movements are still controllable.
There are few research results on using eye trackers with ALS or MS patients.
A former study [6] identified some fundamental requirements for Augmentative
and Alternative Communication (AAC) systems in these patients: communi-
cating instructions, achieve the satisfaction of their needs, clarify their needs,
having an ”affective” communication and transfer informations. The results of
such research, even if they offer significant information, are limited by the lack
of a direct involvement of patients.
A deeper knowledge about real patient needs, and of their caregivers, is
therefore necessary to define and evaluate effective tools for AAC through eye
tracking devices. This paper reports the trials performed, over a span of 2 years,
on a significant fraction of Italian ALS patients. The trials were conducted in
collaboration between Politecnico di Torino, the hospital San Giovanni Battista
of Torino, and the University of Torino (dept. of Neuroscience).
The main aim of the experimentation is to evaluate if and when eye tracking
technologies have a positive impact on patients’ lives.
2 Methodology
The research is based on the following main principles:
– Adoption of Quality of Life (QoL) assessment scales
– Experimentation with off-the-shelf devices
– Involving a large user base.
A multi-disciplinary team, composed by Neurologists, Psychologists, Speech
therapists and Computer Science Engineers, lead the experimentation.
The neurologists select the patients in according with the following recruit-
ment criteria:
– Ethical: patients who are able to understand the aim of the study and to
give an informed consent.
– Motivational: patients who are unable to speech intelligibly and having
various degrees of hand function impairment.
– Efficacy: patients who have basic to good level of computer literacy.
During the trial, each patient uses an eye tracking system for a week in their
own domestic environment.
The research team schedules two visits and one telephone contact for each
patient during the eye tracking lending period. The speech therapists train pa-
tients and their caregivers to calibrate and use the eye tracking system. The
training also includes a brief course about using applications for writing, com-
munication and Internet browsing in eye tracking mode. Other applications are
installed in according to users’ needs and interests.
The psychologists fill in the patients’ assessment questionnaires just before
the training phase. The questionnaires measure the QoL, the satisfaction about
Life, the Depression level, and the perception to represent a burden.
The following international recognized quantitative scales are been adopted:
– Mc Gill scale (MGS). This scale, developed at McGill’s University [3, 4], ana-
lyzes five factors: physical comfort, physical symptoms, psychological symp-
toms, existential comfort and support.
– Satisfaction With Life Scale (SWLS) [5, 8] which evaluates the satisfaction
about life.
– Zung scale: self rating depression scale [9]; it is fast, simple and it has quan-
titative results.
– Self-Perceived Burden Scale (SPBS) [7, 2]: this questionnaire consists of 25
statements about feelings the patients may or may not have about their
relationships with caregivers.
The same questionnaires are proposed again at the end of the evaluation
period with the purpose of verifying the impact of the eye tracker usage on the
measured parameters. A further questionnaire, developed by the ALS center, is
additionally proposed at the end of the lending period. The ALS questionnaire
focuses on qualitative aspects and feelings, and analyzes the time spent with the
system, the training process, subjective satisfaction, and influence on life quality.
3 Experimental settings
The eye tracker used in the experimentation was the Eye Response Technologies’
ERICA Standard System equipped with Assistive and Communication software
such as ERICA keyboard, mouse emulators, Sensory Software’s The Grid. Stan-
dard Windows and Internet applications are also used in the tests.
The experimentation involved 16 patients (12 men, 4 women) from April
2006 to August 2007. The patients average age was 45 years (min 32, max 78).
The patients were in the advanced phase of the disease, in detail: 7 of them were
tracheotomized, 8 had percutaneous endoscopic gastrostomy tube (PEG), while
6 patients where anarthric and 7 had a severe dysarthria.
4 Case studies
Three particular user case studies are hereafter reported to give a qualitative
outlook of the impact of eye tracking technology on ALS patiens. Permission to
publish this information, in a partially anonymous form, has been obtained.
Marco – Marco is 47 and lives in his house with his family. Before the disease he
was a traveling salesman, frequently traveling around the country. At the time
of the experimentation he was using a communication system (virtual keyboard)
with a computer and a foot switch (in scanning mode). When he tried the eye
control system he was very excited; he used a screen keyboard for communication
and for sending emails quickly and easily. More recently, he started having a lot
of problems with his current system because he has less and less movement
on his feet. He really wants an eye control system, but the Piemonte Regional
Government denied him a grant. He later succeeded, thanks to the help of the
Italian ALS Association, to raise funds for buying an eye tracker, an is currently
collaborating with the device manufacturers. He is also in the process of writing
a book, in collaboration with other ALS patients who use eye trackers.
Paolo – Paolo is 52 and lives at home with his wife. Before the illness, he was a
web designer, and he still is. During the experimentation he was using two mouse
devices, one for moving the cursor and the other for clicking. He needs the eye
tracker for his work, only, because he still successfully uses labial movements for
communication with his family. He uses many programs for his work, and tried
them all on the Erica system. The results were positive and he wants to buy
the software and camera add-on to his computer. In the past he tried other eye
tracking systems but he didn’t like them because “they didn’t work well with
web design programs.” He recently lost the ability to use mice as input devices,
and he is waiting for the national health system to fund him the purchase of an
eye tracker.
Domenico – Domenico is a young man, he lives at home with his wife. He was
eager to try the eye control system to be able to speak, for the first time, with his
2-years old nephew, and also to be able to express his feelings with bad words!
When he tried the eye tracker, finally he could speak with his nephew who could
listen for the first time his “voice”.
5 Quantitative Results
During the initial and final meetings of each trial, the responses of the patients
to the various questionnaires were recorded, and SPSS 12.0 was used to analyze
them from a statistical point of view. The test results showed a clear improve-
ment in the perceived quality of life, in both the MGS and SWLS Scales.
A particularly noticeable improvement was shown in the patients’ perception
of their condition overall, including their psychological well-being and physical
symptoms, although the amount of support required by each patient, and their
perceived depression did not show a significant change (less than 0,05). However,
it must be remembered that these results were achieved over a relatively short
trial period of seven days.
More in detail, Figures 1, 2, 3 report the main results on the four main scales.
The McGill scale (Fig. 1) measures a slight, but generalized, improvement on all
aspects of the quality of life that may be attributed to the eye control equipment.
On the other hand, Fig. 2 shows that there were no significant modifications on
depression and burden scores, while we could measure an improvement on the
satisfaction with life scale (Fig. 3).
Fig. 1. Quality of Life (McGill Scale)
Fig. 2. Depression (ZDS) and self-estimated burden (SPBS)
Fig. 3. SWLS (satisfaction with life scale)
Specific evaluations about the eye control device are analyzed using the ALS
Center questionnaire. In particular, we may notice that the vast majority users
are quite satisfied with eye control devices (Fig. 4(d)); they use it quite often
(Fig. 4(a)), and find it easy to use (Fig. 4(b)) and to learn(Fig. 4(c)).
(a) Time of USE (b) Ease of USE
(c) Learning rate (d) Satisfaction
Fig. 4. ALS Centre questionnaire
6 User comments
Users agree that the system is efficient and effective, and allows more complex
communication, beyond the primary needs. In fact, the majority of patients
used the system every day with a high level of satisfaction. They felt that eye-
control was comfortable and flexible, and required relatively little effort. A great
perceived advantage is that, after calibration, the user is independent in using
applications (compared with Plexiglas tables commonly used for eye-contact
dialogs, which rely on a communication partner). For typing applications, users
appreciated the prediction dictionary and the voice synthesis features. On the
other hand, some patients expressed negative comments, which were mainly due
to loss of motivation after some initial technical problems, or to the difficulty in
calibration or the need of repeating the calibration procedure too often. Some
patients using multi focal lenses could not calibrate the system, but this was
solved by changing the glasses. For users less expert with computers, learning
to use the screen keyboard was somewhat difficult. Finally, some patient with
a residual mobility on some parts of their body had difficulties in keeping their
head perfectly still.
7 Conclusions
All patients showed a strong interest in eye tracking systems, and most of them
had already looked for information about this technology. The Erica system has
generally been well accepted and considered easy enough to be used by ALS
patients with severe disability. The patients with worse clinical conditions had
better acceptance.
Eye tracking benefits are lower for patients with residual arm mobility, while
tracheotomized patients had stronger motivation probably because of two main
reasons: anarthria represents the first motivation for communicating and tra-
cheotomized patients have better ventilation, and brain oxygenation, than pa-
tients with dispnea. The patients who tried the eye tracker system perceived an
improvement of QoL because they were able to communicate independently and
the communication was easier, faster and less laborious.
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